UNPA – BREAKING / HHS sends recommendation to DEA to reschedule marijuana
Aug 31, 2023
From: Loren Israelsen <loren@unpa.com>
Date: Thu, Aug 31, 2023 at 8:09 AM
Subject: UNPA — BREAKING / HHS sends recommendation to DEA to reschedule marijuana
To: UNPA HE/C Committee Members <heidi@unpa.com>
Dear Colleagues —
In breaking news yesterday, the Department of Health and Human Services has sent recommendations to the DEA to reschedule marijuana as a Schedule III substance. Currently, marijuana is Schedule I. This action was taken pursuant to an October 2022 request letter from President Biden asking the Secretary of HHS and the Attorney General to review how marijuana is currently scheduled under federal law.
The immediate effect was a jump in publicly traded cannabis stocks. Whether this will have any effect on FDA’s views with respect to the status of CBD/hemp extracts remains to be seen.
We will be following this closely and keep you posted on developments.
Names PK Davé CEO of Sabinsa’s Consumer Goods Division February 3, 2025 Sabinsa, the multi-national health science company known for providing sustainable, natural,
Sirio Pharma Launches SirioSure Quality Assurance Initiative for Nutrition Products Comprehensive QA/QC program runs full product lifespan, from ingredient sourcing and data-informed development
